Idarubicin-Loaded DEB-TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score-matching analysis - Fan, W; Zhu, B; Yue, S (Cancer Med, 2023)
et al.